Estimation of the total effective dose from low-dose CT scans and radiopharmaceutical administrations delivered to patients undergoing SPECT/CT explorations

Annals of Nuclear Medicine

Volumn 27, Issue 7, 2013, Pages 610-617

  Montes, Carlos ^a,b   Tamayo, Pilar ^a,b   Hernandez, Jorge ^a   Gomez Caminero, Felipe ^a   García, Sofia ^a   Martín, Carlos ^a   Rosero, Angela ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA IBSAL   (Spain)

Author keywords

Background Equivalent Radiation Time; Effective dose; Radiopharmaceutical; SPECT CT

Indexed keywords

ETIDRONIC ACID TC 99M; GALLIUM 67; INDIUM 111; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TETROFOSMIN TC 99M; TRACER;

ARTICLE; BACKGROUND EQUIVALENT RADIATION TIME; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; DOSE RESPONSE; HEART MUSCLE PERFUSION; HUMAN; IONIZING RADIATION; LOW ENERGY RADIATION; LYMPHOMA; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; WHOLE BODY CT;

BACKGROUND RADIATION; ENVIRONMENTAL EXPOSURE; HUMANS; RADIATION DOSAGE; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84882585954     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-013-0724-6     Document Type: Article

References (30)

1. Czernin J, Allen-Auerbach M, Schelbert HR. Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006. J Nucl Med. 2007;48(Suppl 1):78S-88S.
2. Von Schulthess GK, Steinert HC, Hany TF. Integrated PET/CT: current applications and future directions. Radiology. 2006;238:405-22.
3. Núñez R, Erwin WD, Wendt RE 3rd, Stachowiak A, Mar M, Stevens D, et al. Acquisition parameters for oncologic imaging with a new SPECT/multislice CT scanner. Mol Imaging Biol. 2010;12:110-38.
4. Chen J, Caputlu-Wilson SF, Shi H, Galt JR, Faber TL, Garcia EV. Automated quality control of emission-transmission misalignment for attenuation correction in myocardial perfusion imaging with SPECT-CT systems. J Nucl Cardiol. 2006;13:43-9.
5. The 2007 Recommendations of the International Commission On Radiological Protection. ICRP publication 103. Ann ICRP. 2007;37:1-332.
6. International Commission on Radiological Protection. Recommendations of the International Commission on Radiological Protection. ICRP Publication 26. Ann ICRP 1(3). Oxford: Pergamon Press; 1971.
7. 1990 Recommendations of the International Commission on Radiological Protection. Ann ICRP 1991;21:1-201.
8. ICRP Publication 106: Radiation dose to patients from radiopharmaceuticals: Addendum 3 to ICRP Publication 53. Ann ICRP. 2008;38:1-197.
9. ICRP Publication 80: Radiation dose to patients from radiopharmaceuticals, Addendum to ICRP Publication 53. Ann ICRP. 1998;28:1-126.
10. ICRP Publication 53: Radiation dose to patients from radiopharmaceuticals. Ann ICRP. 1987;18:1-377.
11. Pujades MC, Martí JF, Olivas C, Bello P, Mateo A. Application of ICRP-103 in the calculation of effective dose associated to nuclear medicine tests. Rev Esp Med Nucl. 2010;29:114-21.
12. Jessen KA, Panzer W, Shrimpton PC. European guidelines on quality criteria for computed tomography. Brussels, Belgium: European Commission, 2000: EUR 16262.
13. Bongartz G, Golding SJ, Juriket AG. European guidelines for multislice computed tomography. Brussels, Belgium: European Commission, 2004: FIGM-CT2000-20078-CT-TIP.
14. Christner JA, Kofler JM, McCollough CH. Estimating effective dose for CT using dose-length product compared with using organ doses: consequences of adopting international commission on radiological protection publication 103 or dual-energy scanning. AJR Am J Roentgenol. 2010;194:881-9.
15. Deak P, Smal Y, Kalender WA. Multisection CT protocols: sex- and age-specific conversion factors used to determine effective dose from dose-length product. Radiology. 2010;257:158-66.
16. United Nations Scientific Committee on the effects of Atomic Radiation. Sources and effects of ionizing radiation UNSCEAR 2008 report vol. I sources of ionizing radiation. Vienna: United Nations; 2008.
17. Gregory KJ, Bibbo G, Pattison JE. On the uncertainties in effective dose estimates of adult CT head scans. Med Phys. 2008;35:3501-10.
18. Sawyer LJ, Starritt HC, Hiscock SC, Evans MJ. Effective doses to patients from CT acquisitions on the GE Infinia Hawkeye: a comparison of calculation methods. Nucl Med Commun. 2008;29:144-9.
19. Nagel HD. Radiation exposure in computed tomography. Fundamentals, influencing parameters, dose assessment, optimization, scanner data, terminology. 4th ed. Hamburg: CTB Publications; 2002.
20. Kalender WA, Schmidt B, Zankl M, Schmidt M. A PC program for estimating organ dose and effective dose values in computed tomography. Eur Radiol. 1999;9:555-62.
21. Myronakis M, Perisinakis K, Tzedakis A, Gourtsoyianni S, Damilakis J. Evaluation of a patient-specific Monte Carlo software for CT dosimetry. Radiat Prot Dosimetry. 2009;133:248-55.
22. Brix G, Lechel U, Glatting G, Ziegler SI, Münzing W, Müller SP, et al. Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations. J Nucl Med. 2005;46:608-13.
23. Mettler FA Jr, Huda W, Yoshizumi TT, Mahesh M. Effective doses in radiology and diagnostic nuclear medicine: a catalog. Radiology. 2008;248:254-63.
24. Larkin AM, Serulle Y, Wagner S, Noz ME. Friedman K quantifying the increase in radiation exposure associated with SPECT/CT compared to SPECT alone for routine nuclear medicine examinations. Int J Mol Imaging. 2011;2011:897202.
25. Khamwan K, Krisanachinda A, Pasawang P. The determination of patient dose from (18)F-FDG PET/CT examination. Radiat Prot Dosimetry. 2010;41:50-5.
26. Administration of Radioactive Substances Advisory Committee. Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources. London: Health Protection Agency; 2006.
27. Venero CV, Heller GV, Bateman TM, McGhie AI, Ahlberg AW, Katten D, et al. A multicenter evaluation of a new post-processing method with depth-dependent collimator resolution applied to full-time and half-time acquisitions without and with simultaneously acquired attenuation correction. J Nucl Cardiol. 2009;16:714-25.
28. Kumar S, Pandey AK, Sharma P, Malhotra A, Kumar R. Optimization of the CT acquisition protocol to reduce patient dose without compromising the diagnostic quality for PET-CT: a phantom study. Nucl Med Commun. 2012;33:164-70.
29. Xia T, Alessio AM, De Man B, Manjeshwar R, Asma E, Kinahan PE. Ultra-low dose CT attenuation correction for PET/CT. Phys Med Biol. 2012;57:309-28.
30. Martin CJ. Effective dose: how should it be applied to medical exposures? Br J Radiol. 2007;80:639-47.